IN2015DN02600A - - Google Patents

Download PDF

Info

Publication number
IN2015DN02600A
IN2015DN02600A IN2600DEN2015A IN2015DN02600A IN 2015DN02600 A IN2015DN02600 A IN 2015DN02600A IN 2600DEN2015 A IN2600DEN2015 A IN 2600DEN2015A IN 2015DN02600 A IN2015DN02600 A IN 2015DN02600A
Authority
IN
India
Prior art keywords
rivaroxaban
compound
formula
preparation
base
Prior art date
Application number
Inventor
Salman Hashmi Mohamad
Pal Sachdeva Yoginder
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN2600DEN2015 priority Critical patent/IN2015DN02600A/en
Publication of IN2015DN02600A publication Critical patent/IN2015DN02600A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Abstract

The present invention provides a process for the preparation of rivaroxaban in a process that includes cyclizing a compound of Formula( U) with a dialkyl carbonate in the presence of a base.
IN2600DEN2015 2012-09-26 2013-09-26 IN2015DN02600A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2600DEN2015 IN2015DN02600A (en) 2012-09-26 2013-09-26

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN3005DE2012 2012-09-26
PCT/IB2013/058897 WO2014049552A2 (en) 2012-09-26 2013-09-26 Process for the preparation of rivaroxaban
IN2600DEN2015 IN2015DN02600A (en) 2012-09-26 2013-09-26

Publications (1)

Publication Number Publication Date
IN2015DN02600A true IN2015DN02600A (en) 2015-09-18

Family

ID=49765588

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2600DEN2015 IN2015DN02600A (en) 2012-09-26 2013-09-26

Country Status (4)

Country Link
US (1) US20150218145A1 (en)
EP (1) EP2900663A2 (en)
IN (1) IN2015DN02600A (en)
WO (1) WO2014049552A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016030669A1 (en) * 2014-08-25 2016-03-03 Cipla Limited Process for the preparation of rivaroxaban

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2655369A1 (en) * 1976-12-03 1978-06-08 Schering Ag 5- (SUBST. PHENYL) -OXAZOLIDINONE AND THEIR SULFUR ANALOGS AND PROCESS FOR THEIR PRODUCTION
DE19962924A1 (en) 1999-12-24 2001-07-05 Bayer Ag Substituted oxazolidinones and their use
DE10300111A1 (en) 2003-01-07 2004-07-15 Bayer Healthcare Ag Process for the preparation of 5-chloro-N - ({(5S) -2-oxo-3- [4- (3-oxo-4-morpholinyl) phenyl] -1,3-oxazolidin-5-yl} methyl ) -2-thiophenecarboxamide
EP2354128A1 (en) * 2010-02-10 2011-08-10 Sandoz Ag Method for the preparation of rivaroxaban
US20130253187A1 (en) * 2010-09-14 2013-09-26 Medichem, S.A. Process for Determining the Suitability for Distribution of a Batch of Thiophene-2-Carboxamide Derivative
WO2013046211A1 (en) * 2011-09-27 2013-04-04 Symed Labs Limited Processes for the preparation of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl) phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophene-carboxamide and intermediates thereof
WO2013164833A1 (en) * 2012-05-02 2013-11-07 Symed Labs Limited Improved process for preparing rivaroxaban using novel intermediates

Also Published As

Publication number Publication date
WO2014049552A2 (en) 2014-04-03
EP2900663A2 (en) 2015-08-05
WO2014049552A3 (en) 2014-05-15
US20150218145A1 (en) 2015-08-06

Similar Documents

Publication Publication Date Title
PH12017501176A1 (en) Pyruvate kinase activators for use therapy
IN2014MN02574A (en)
MX355728B (en) Kinase inhibitors.
MX2015002487A (en) Process for the preparation of teneligliptin.
IN2014CN02639A (en)
IN2015DN00598A (en)
SG10201805410XA (en) Therapeutic agent or prophylactic agent for dementia
MY167698A (en) Pyrazoloquinoline Derivative
MX341456B (en) Amino-quinolines as kinase inhibitors.
UY34654A (en) BETA-SECRETASA INHIBITORS
MX2014007829A (en) Fused tricyclic compounds as raf kinase inhibitors.
EP2566477A4 (en) Amino-quinolines as kinase inhibitors
CR20140306A (en) FLUORMETIL -5,6-DIHIDRO-4H- [1,3] OXAZINES
GB201103836D0 (en) Conjugation process
UY34666A (en) ARILÉTER BASED KINASE INHIBITORS
IN2014DN09450A (en)
MX337094B (en) Process and intermediates for preparing integrase inhibitors.
GEP201706626B (en) Synthesis of (s)-nifuratel
IN2014DN06192A (en)
AP2015008532A0 (en) Syk kinase inhibitors as treatment for malaria
GB201107985D0 (en) Process
IN2014DN10209A (en)
IN2013MU01113A (en)
IN2014DN09451A (en)
MX352305B (en) Processes for preparing toothpaste compositions.